AdGVPEDF.11D

· GenVec

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AdGVPEDF.11D, covering 2011-05-12 to 2011-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) [Phase 1]